US12215132B2ActiveUtilityA1
Methods, compositions and uses thereof for reversing sarcopenia
Est. expiryApr 17, 2040(~13.7 yrs left)· nominal 20-yr term from priority
A61K 38/22C07K 2319/00C07K 2319/30A61P 21/06A61K 38/204A61K 38/39A61P 21/00C07K 14/575C07K 14/5412A61K 38/00
61
PatentIndex Score
0
Cited by
78
References
4
Claims
Abstract
Exemplary methods, compositions and uses thereof can be provided for preventing, reducing and/or treating loss of muscle function. In particular, e.g., it is possible to administer to a subject a pharmaceutical composition comprising a therapeutically effective amount of an agent that enhances Interleukin-6 (IL) release during exercise, and optionally a pharmaceutically acceptable carrier or excipient.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method for reducing loss of muscle function in a subject with sarcopenia, comprising: administering to the subject a pharmaceutical composition which comprises a therapeutically effective amount of Interleukin-6-Bisphosphonate fusion peptide.
2. The method of claim 1 , wherein the subject is a human.
3. The method of claim 1 , wherein the Interleukin-6-Bisphosphonate fusion peptide further reduces loss of muscle mass.
4. The method of claim 1 , wherein the pharmaceutical composition further comprises a pharmaceutically acceptable carrier or excipient.Join the waitlist — get patent alerts
Track US12215132B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.